EUTM file information



February 17, 2021

Trademark Summary

The trademark application Baricitinib was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). Application withdrawn.

The application was filed in English (German was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the treatment of coronavirus and infectious diseases and pharmaceutical preparations..